The Duration and Safety of Osteoporosis Treatment (eBook)

Stuart L. Silverman, MD, FACP, FACRCedars-Sinai Medical CenterDivision of RheumatologyDepartment of MedicineLos Angeles, CA, USAUniversity of California Los AngelesDavid Geffen School of MedicineLos Angeles, CA, USABo Abrahamsen, MD, PhDUniversity of Southern DenmarkOdense Patient Data Explorative NetworkInstitute of Clinical ResearchOdense, DenmarkHolbæk HospitalDepartment of MedicineHolbæk, Denmark

Foreword   Juliet CompstonPrefaceChapter 1 Osteoporosis: Pathophysiology & Epidemiology          Rebecca J. Moon, Cyrus Cooper, and Nicholas C. HarveyChapter 2 Antiresorptives           R. Graham G. Russell, Maria K. Tsoumpra, Frank H. Ebetino, Michael PazianasChapter 3 Anabolics          Erik Fink EriksenChapter 4 Tools for Assessing Fracture Risk and for Treatment Monitoring          William D. Leslie, Lisa M. Lix, and Suzanne N. MorinChapter 5 Treatment Failure          Elisa Torres del Pliego, Daniel Prieto-Alhambra, and Adolfo Díez-PerezChapter 6 Epidemiology of Atypical Subtrochanteric and Femoral Shaft Fractures          Jeri W. NievesChapter 7 Bisphosphonate-Related Atypical Femoral Fractures and Their Radiographic Features           Joseph C. Giaconi and C. Travis WattersonChapter 8  Factors Contributing to Atypical Femoral Fractures            Adele L. Boskey and Marjolein C. H. van der MeulenChapter 9  Clinical Presentation of Atypical Femur Fractures            Yelena Bogdan and Thomas A. EinhornChapter 10  Effects of Antiresorptive Therapy on Bone Microarchitecture            Joy N. Tsai and Mary L. BouxseinChapter 11  Management of Atypical Femoral Fractures            Joseph M. Lane, Libi Z. Galmer, David S. Wellman, Abigail L. Campbell, Jonathan E. JoChapter 12  Osteonecrosis of the Jaw: Clinico-Pathologic and Radiologic Features            Parish P. Sedghizadeh and Allan C. JonesChapter 13  Epidemiology of Osteonecrosis of the Jaws from Antiresorptive Treatment             Morten SchiødtChapter 14  Management of Osteonecrosis of the Jaw in Patients Receiving Antiresorptive Treatment                 Morten SchiødtChapter 15  Long-Term Efficacy and Safety of Treatments for Osteoporosis             Socrates E. PapapoulosChapter 16  Management of Drug Holidays            Christian Roux and Karine BriotChapter 17  Patients Who Do Not Take Their Osteoporosis Medications:  Can We Help Them Become Compliant?             Deborah T. GoldChapter 18  Fractures and Healing on Antiresorptive Therapy            Eli Kupperman and Susan V. BukataChapter 19 Antiresorptive Therapy and Mortality and Cancer Incidence            Peter VestergaardChapter 20  Other Safety Concerns            Michael R. McClungChapter 21  The Impact of Regulatory and Scientific Organizations Recommendations on Clinical Decision Making            Alexandra Papaioannou, Arnav Agarwal, and Sarah KarampatosChapter 22  Integrated Clinical View on Long-Term Management of  Patients with Osteoporosis             E. Michael LewieckiChapter 23  Conclusions            Stuart L. Silverman and Bo Abrahamsen